verified SJR 1,209 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Oxford University Press

workspace_premium Q1 — Infectious Diseases lock Subscription

Journal of Antimicrobial Chemotherapy

Journal of Antimicrobial Chemotherapy is a journal indexed in SJR in Infectious Diseases and Pharmacology with an H index of 229. It has a price of 4700 €. It has an SJR impact factor of 1,209 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,209.

Journal of Antimicrobial Chemotherapy focuses its scope in these topics and keywords: resistance, antimicrobial, patients, study, antibiotic, hiv, acinetobacter, staphylococcus, isolates, aureus, ...

ISSN: 0305-7453

Publisher: Oxford University Press

Category: Infectious Diseases

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,209 Q1

H-index 229

Acceptance rate pie_chart

19% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

4.700 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,209

H-index

229

Docs (year)

437

Docs 3y

1459

Total refs

13353

Cites 3y

4966

Citable 3y

1311

Cites/Doc 2y

3.29

Ref/Doc

30.56

Immediate OA

4700 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antibiotic resistance and production of extended-spectrum beta-Mactamases amongst Klebsiella spp. from intensive care units in Europe

Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole

Comment on: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii

Comment on: Extension of the hydrolysis spectrum of AmpC -lactamase of Escherichia coli due to amino acid insertion in the H-10 helix

Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B

Chlorhexidine hypersensitivity of ciprofloxacin-resistant variants of Pseudonwnas aeruginosa PAO

Characterization of acquired -lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons

Cerebrospinal fluid penetration of trimethoprim-sulphamethoxazole in two patients with Gram-negative bacillary meningitis

Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia

Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase

Biphasic kinetics of bacterial killing by quinolones

beta-Lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila

SHOW MORE ARTICLES

Bactericidal in-vitro activity of betalactams and betalactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides

-Lactam resistance amongst Enterobacter species

Antagonistic interaction of rifampicin and trimethoprim

Alterations to the penicillin-binding proteins in the Bacteroides fragilis group: a mechanism for non-beta-lactamase mediated cefoxitin resistance

Aetiology and treatment of community-acquired pneumonia in adults: an historical perspective

Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential

Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and - resistant Trichomonas vaginalis and Tritrichomonas foetus [In Process Citation]

Activities of metronidazole and niridazole against Trichomonas vaginalis clinical isolates

Acquired resistance to echinocandins in Candida albicans: case report and review

A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae

A mechanism of rifamycin inhibition and resistance in Pseudomonas aeruginosa

2-Hydroxypropyl- -cyclodextrin improves the effectiveness of albendazole against encapsulated larvae of Trichinella spiralis in a murine model

FAQs

Journal of Antimicrobial Chemotherapy has an SJR of 1,209 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 4700 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Journal of Antimicrobial Chemotherapy is 19%.

Journal of Antimicrobial Chemotherapy

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Antimicrobial Chemotherapy?

What is the APC / publication cost?

What is the acceptance rate?